Inclusion Criteria:  age 21 and older bilateral implantation of a Finevision trifocal diffractive IOL (either a POD FT in both eyes or a POD FT in the study eye and a POD F in the contralateral eye) bilateral cataract surgery with grade 1-4 cataract regular corneal astigmatism of 1.00 D or more before surgery in the study eye previous written informed consent to surgery. Written informed consent to participation in the study and data protection  Exclusion Criteria:  relevant concomitant ophthalmic diseases (such as pseudoexfoliation, glaucoma, traumatic cataract and other co-morbidity that could affect capsular bag stability (e.g. Marfan syndrome) irregular corneal astigmatism, any abnormality in corneal topography systemic disease with impact on visual outcome disability to understand and/or fill in patient questionnaires history of other relevant previous ocular surgery (such as corneal surgery, glaucoma surgery, vitreoretinal surgery) which might affect capsular stability or visual outcomes expected residual cylinder ≥ 0.50 D